IBS Asset Based Lending

We provide creative asset-based financing to small & middle-market-sized companies throughout the continental United States. IBS Institutional Capital's (IBS) Asset Based Lending (ABL) Program provides low-cost capital for acquisitions, dividend recapitalizations, growth, debt restructurings, debtor-in-possession, and turnarounds. As a non-recourse lender, IBS provides ABL financing to hyper-growth companies that require scalable credit lines based on their assets and projected growth. General parameters include:


General Lending Parameters

Loan Commitments:

  • $3,000,000 to $50,000,000
  • Dedicated syndication capabilities up to $50,000,000


  • Up to 80% of eligible accounts receivable (foreign receivables financed in over 30 countries)
  • Up to 100% of eligible purchase orders
  • Up to 60% of eligible inventory with higher advance rates available based upon appraisal.


Term loans

  • Up to 80% of the liquidation value of equipment
  • Up to 75% of the appraised fair market value of a real estate
  • Capital expenditure facilities available to finance new equipment purchases



  • Interest-only- inventory assets
  • Up to 7 years – equipment loans
  • Up to 30 years – real estate loans


Typical Uses

  • Refinancing/Working Capital
  • Acquisition
  • Growth
  • Distress and Turnaround


Learn how IBS drives the success of small and middle-market-sized companies through its nation-leading corporate finance programs by downloading our brochures and guides and visiting the links below. Reach out to a Relationship Manager for more information.



Short Term Bridge 

Expansion Term Loan

Unitranche Term Facility

Intellectual Property Finance

Contact Us

IBS Family of Companies


Fort Lauderdale Office

Mailing and Appointments

401 E Las Olas Blvd

Suite 1400

Fort Lauderdale, FL 33301


West Palm Beach Office 

The Wagg Building 

215 South Olive Ave

Suite 201

W.Palm Beach, FL 33401



Capital Funding Solutions Office

2021 Tyler Street 

Suite 208

Hollywood, Florida 33020



Phone: +1 954 889-5827



Or use our contact form.

Print Print | Sitemap
© Content copyright 2021 IBS Institutional Capital. All rights reserved. This website is intended for illustration purposes only. Despite our efforts to be accurate, these pages may contain errors and information that is no longer current. The information published on this website is subject to change on a regular basis without notice.